Patent ID: 11879005
Assignee: NUMAB THERAPEUTICS AG
Field: Biotechnology (Chemistry)
Classification: CPC A  C | IPC C

Claim 1:
2. The hetero-dimeric protein of claim 1, further comprising
(v) a fourth functional domain that is fused via a fourth polypeptide linker to said first or said second amino acid sequence, wherein said fourth functional domain has specificity to said first, second or third target antigen;
(vi) a fourth and a fifth functional domain that are fused via a fourth and a fifth polypeptide linker, respectively, to said first and said second amino acid sequence, wherein said fourth and fifth functional domain, independently of each other, have specificity to said first, second or third target antigen; or
(vi) a fourth, a fifth and a sixth functional domain that are fused via a fourth, a fifth and a sixth polypeptide linker, respectively, to said first and said second amino acid sequence, wherein said fourth, fifth and sixth functional domain, independently of each other, have specificity to said first, second or third target antigen.